Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of EUR 2.04 billion. The enterprise value is 9.60 billion.

Market Cap	2.04B
Enterprise Value	9.60B

Important Dates

The last earnings date was Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Feb 21, 2025

Share Statistics

Current Share Class	259.96M
Shares Outstanding	n/a
Shares Change (YoY)	+1.17%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	258.77M

Valuation Ratios

The trailing PE ratio is 2.93 and the forward PE ratio is 2.30.

PE Ratio	2.93
Forward PE	2.30
PS Ratio	0.35
PB Ratio	4.06
P/TBV Ratio	n/a
P/FCF Ratio	2.83
P/OCF Ratio	2.35
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.07, with an EV/FCF ratio of 13.35.

EV / Earnings	13.83
EV / Sales	1.70
EV / EBITDA	6.07
EV / EBIT	7.63
EV / FCF	13.35

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 16.52.

Current Ratio	1.67
Quick Ratio	0.77
Debt / Equity	16.52
Debt / EBITDA	5.09
Debt / FCF	11.53
Interest Coverage	2.73

Financial Efficiency

Return on equity (ROE) is 254.24% and return on invested capital (ROIC) is 9.58%.

Return on Equity (ROE)	254.24%
Return on Assets (ROA)	6.98%
Return on Invested Capital (ROIC)	9.58%
Return on Capital Employed (ROCE)	13.27%
Revenue Per Employee	582,321
Profits Per Employee	69,390
Employee Count	10,000
Asset Turnover	0.50
Inventory Turnover	2.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.32% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.32%
50-Day Moving Average	13.60
200-Day Moving Average	16.00
Relative Strength Index (RSI)	0.31
Average Volume (20 Days)	28

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.67

Income Statement

In the last 12 months, Organon & Co. had revenue of EUR 5.82 billion and earned 693.90 million in profits. Earnings per share was 2.66.

Revenue	5.82B
Gross Profit	3.33B
Operating Income	1.29B
Pretax Income	621.73M
Net Income	693.90M
EBITDA	1.57B
EBIT	1.29B
Earnings Per Share (EPS)	2.66

Full Income Statement

Balance Sheet

The company has 506.08 million in cash and 8.29 billion in debt, giving a net cash position of -7.78 billion.

Cash & Cash Equivalents	506.08M
Total Debt	8.29B
Net Cash	-7.78B
Net Cash Per Share	n/a
Equity (Book Value)	501.46M
Book Value Per Share	1.94
Working Capital	1.62B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 867.84 million and capital expenditures -148.96 million, giving a free cash flow of 718.88 million.

Operating Cash Flow	867.84M
Capital Expenditures	-148.96M
Free Cash Flow	718.88M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 57.18%, with operating and profit margins of 22.23% and 11.92%.

Gross Margin	57.18%
Operating Margin	22.23%
Pretax Margin	10.68%
Profit Margin	11.92%
EBITDA Margin	26.93%
EBIT Margin	22.23%
FCF Margin	12.35%

Dividends & Yields

This stock pays an annual dividend of 1.04, which amounts to a dividend yield of 10.18%.

Dividend Per Share	1.04
Dividend Yield	10.18%
Dividend Growth (YoY)	0.97%
Years of Dividend Growth	n/a
Payout Ratio	39.73%
Buyback Yield	-1.17%
Shareholder Yield	9.02%
Earnings Yield	34.08%
FCF Yield	35.30%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	n/a